The portfolio maintains a sizable cost advantage over competitors, priced within the cheapest fee quintile among peers.
ALPS Medical Breakthroughs ETF SBIO
Morningstar’s Analysis SBIO
Will SBIO outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 32.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Viking Therapeutics Inc | 5.05 | 5.4 Mil | Healthcare |
Cerevel Therapeutics Holdings Inc Ordinary Shares | 5.00 | 5.4 Mil | Healthcare |
Vaxcyte Inc Ordinary Shares | 4.60 | 4.9 Mil | Healthcare |
Revolution Medicines Inc Ordinary Shares | 4.01 | 4.3 Mil | Healthcare |
Alpine Immune Sciences Inc | 2.78 | 3.0 Mil | Healthcare |
Alkermes PLC | 2.62 | 2.8 Mil | Healthcare |
Crinetics Pharmaceuticals Inc | 2.44 | 2.6 Mil | Healthcare |
Axsome Therapeutics Inc | 2.25 | 2.4 Mil | Healthcare |
Summit Therapeutics Inc Ordinary Shares | 2.13 | 2.3 Mil | Healthcare |
Xenon Pharmaceuticals Inc | 2.00 | 2.1 Mil | Healthcare |